Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.

Spotted fever group rickettsiae are tick-borne obligate intracellular bacteria that infect microvascular endothelial cells. Humans and mammalian infection results in endothelial cell barrier dysfunction and increased vascular permeability. We previously demonstrated that treatment of Rickettsia park...

Full description

Bibliographic Details
Main Authors: Andrés F Londoño, Jennifer M Farner, Marlon Dillon, Dennis J Grab, Yuri Kim, Diana G Scorpio, J Stephen Dumler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-02-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0011993&type=printable
_version_ 1797263520627163136
author Andrés F Londoño
Jennifer M Farner
Marlon Dillon
Dennis J Grab
Yuri Kim
Diana G Scorpio
J Stephen Dumler
author_facet Andrés F Londoño
Jennifer M Farner
Marlon Dillon
Dennis J Grab
Yuri Kim
Diana G Scorpio
J Stephen Dumler
author_sort Andrés F Londoño
collection DOAJ
description Spotted fever group rickettsiae are tick-borne obligate intracellular bacteria that infect microvascular endothelial cells. Humans and mammalian infection results in endothelial cell barrier dysfunction and increased vascular permeability. We previously demonstrated that treatment of Rickettsia parkeri-infected cells with the calcium channel blocker benidipine significantly delayed vascular barrier permeability. Thus, we hypothesized that benidipine, known to be safe and effective for other clinical processes, could reduce rickettsia-induced vascular permeability in vivo in an animal model of spotted fever rickettsiosis. Based on liver, lung and brain vascular FITC-dextran extravasation studies, benidipine did not reliably impact vascular permeability. However, it precipitated a deleterious effect on responses to control sublethal R. parkeri infection. Animals treated with benidipine alone had no clinical signs or changes in histopathology and splenic immune cell distributions. Benidipine-treated infected animals had marked increases in tissue and blood bacterial loads, more extensive inflammatory histopathologic injury, and changes in splenic architecture and immune cell distributions potentially reflecting diminished Ca2+ signaling, reduced innate immune cell activation, and loss of rickettsial propagation control. Impaired T cell activation by R. parkeri antigen in the presence of benidipine was confirmed in vitro with the use of NKT cell hybridomas. The unexpected findings stand in stark contrast to recent discussions of the benefits of calcium channel blockers for viral infections and chronic infectious or inflammatory diseases. A role for calcium channel blockers in exacerbation of human rickettsiosis and acute inflammatory infections should be evaluated by a retrospective review of patient's outcomes and medications.
first_indexed 2024-04-25T00:14:19Z
format Article
id doaj.art-303aaa7626214e9fa6ff891afd627703
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-04-25T00:14:19Z
publishDate 2024-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-303aaa7626214e9fa6ff891afd6277032024-03-13T05:31:47ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352024-02-01182e001199310.1371/journal.pntd.0011993Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.Andrés F LondoñoJennifer M FarnerMarlon DillonDennis J GrabYuri KimDiana G ScorpioJ Stephen DumlerSpotted fever group rickettsiae are tick-borne obligate intracellular bacteria that infect microvascular endothelial cells. Humans and mammalian infection results in endothelial cell barrier dysfunction and increased vascular permeability. We previously demonstrated that treatment of Rickettsia parkeri-infected cells with the calcium channel blocker benidipine significantly delayed vascular barrier permeability. Thus, we hypothesized that benidipine, known to be safe and effective for other clinical processes, could reduce rickettsia-induced vascular permeability in vivo in an animal model of spotted fever rickettsiosis. Based on liver, lung and brain vascular FITC-dextran extravasation studies, benidipine did not reliably impact vascular permeability. However, it precipitated a deleterious effect on responses to control sublethal R. parkeri infection. Animals treated with benidipine alone had no clinical signs or changes in histopathology and splenic immune cell distributions. Benidipine-treated infected animals had marked increases in tissue and blood bacterial loads, more extensive inflammatory histopathologic injury, and changes in splenic architecture and immune cell distributions potentially reflecting diminished Ca2+ signaling, reduced innate immune cell activation, and loss of rickettsial propagation control. Impaired T cell activation by R. parkeri antigen in the presence of benidipine was confirmed in vitro with the use of NKT cell hybridomas. The unexpected findings stand in stark contrast to recent discussions of the benefits of calcium channel blockers for viral infections and chronic infectious or inflammatory diseases. A role for calcium channel blockers in exacerbation of human rickettsiosis and acute inflammatory infections should be evaluated by a retrospective review of patient's outcomes and medications.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0011993&type=printable
spellingShingle Andrés F Londoño
Jennifer M Farner
Marlon Dillon
Dennis J Grab
Yuri Kim
Diana G Scorpio
J Stephen Dumler
Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.
PLoS Neglected Tropical Diseases
title Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.
title_full Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.
title_fullStr Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.
title_full_unstemmed Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.
title_short Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.
title_sort benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0011993&type=printable
work_keys_str_mv AT andresflondono benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis
AT jennifermfarner benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis
AT marlondillon benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis
AT dennisjgrab benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis
AT yurikim benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis
AT dianagscorpio benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis
AT jstephendumler benidipineimpairsinnateimmunityconvertingsublethaltolethalinfectionsinamurinemodelofspottedfeverrickettsiosis